medroxyprogesterone acetate has been researched along with Gonadal Dysgenesis, 46, XX in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calis, KA; Corrigan, EC; Kalantaridou, SN; Nelson, LM; Troendle, JF; Vanderhoof, VH | 1 |
1 trial(s) available for medroxyprogesterone acetate and Gonadal Dysgenesis, 46, XX
Article | Year |
---|---|
Sexual function in young women with spontaneous 46,XX primary ovarian insufficiency.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Cross-Sectional Studies; Double-Blind Method; Estrogen Replacement Therapy; Estrogens; Female; Gonadal Dysgenesis, 46,XX; Humans; Medroxyprogesterone Acetate; Primary Ovarian Insufficiency; Prospective Studies; Sexual Behavior; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Testosterone; Treatment Outcome; Young Adult | 2008 |